Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pulmonx Corporation

Clinical trials sponsored by Pulmonx Corporation, explained in plain language.

Pulmonx Corporation LUNG NASDAQ

Develops minimally invasive treatments for chronic obstructive pulmonary disease.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

Lung valve registry shows promise for emphysema patients

Disease control Completed

This completed French registry tracked 155 adults with severe emphysema or COPD who received Zephyr Valves, tiny devices placed in the lungs to help them work better. The goal was to see if the treatment safely improves breathing over 12 months. Researchers measured lung function…

Sponsor: Pulmonx Corporation • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC